Advisors Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$170K Sell
3,085
-751
-20% -$41.3K ﹤0.01% 1135
2025
Q1
$271K Sell
3,836
-388
-9% -$27.4K 0.01% 1061
2024
Q4
$278K Sell
4,224
-7,227
-63% -$475K 0.01% 1060
2024
Q3
$805K Buy
11,451
+180
+2% +$12.7K 0.01% 789
2024
Q2
$928K Buy
11,271
+889
+9% +$73.2K 0.02% 751
2024
Q1
$907K Buy
10,382
+1,240
+14% +$108K 0.02% 760
2023
Q4
$881K Sell
9,142
-991
-10% -$95.6K 0.02% 750
2023
Q3
$897K Buy
10,133
+612
+6% +$54.2K 0.02% 745
2023
Q2
$825K Buy
9,521
+1,083
+13% +$93.9K 0.02% 804
2023
Q1
$821K Buy
8,438
+1,159
+16% +$113K 0.02% 819
2022
Q4
$753K Buy
7,279
+6,887
+1,757% +$713K 0.02% 839
2022
Q3
$33K Sell
392
-575
-59% -$48.4K ﹤0.01% 1397
2022
Q2
$80K Sell
967
-11,675
-92% -$966K ﹤0.01% 1316
2022
Q1
$975K Sell
12,642
-743
-6% -$57.3K 0.02% 812
2021
Q4
$1.18M Sell
13,385
-262
-2% -$23.2K 0.02% 786
2021
Q3
$1.06M Sell
13,647
-5,942
-30% -$459K 0.02% 796
2021
Q2
$1.64M Sell
19,589
-126
-0.6% -$10.5K 0.02% 662
2021
Q1
$1.49M Sell
19,715
-1,658
-8% -$125K 0.02% 691
2020
Q4
$1.87M Buy
21,373
+3,873
+22% +$340K 0.03% 580
2020
Q3
$1.33M Buy
17,500
+8,010
+84% +$609K 0.02% 622
2020
Q2
$1.17M Buy
9,490
+6,329
+200% +$780K 0.02% 648
2020
Q1
$267K Buy
3,161
+57
+2% +$4.82K 0.01% 1039
2019
Q4
$262K Sell
3,104
-103
-3% -$8.69K ﹤0.01% 1140
2019
Q3
$216K Sell
3,207
-215
-6% -$14.5K ﹤0.01% 1171
2019
Q2
$293K Sell
3,422
-134
-4% -$11.5K 0.01% 1110
2019
Q1
$316K Sell
3,556
-3,758
-51% -$334K 0.01% 1221
2018
Q4
$623K Sell
7,314
-2,621
-26% -$223K 0.01% 920
2018
Q3
$963K Sell
9,935
-842
-8% -$81.6K 0.02% 848
2018
Q2
$1.02M Sell
10,777
-4,452
-29% -$419K 0.02% 835
2018
Q1
$1.24M Sell
15,229
-508
-3% -$41.2K 0.02% 759
2017
Q4
$1.4M Sell
15,737
-468
-3% -$41.7K 0.02% 708
2017
Q3
$1.51M Sell
16,205
-5,814
-26% -$541K 0.03% 707
2017
Q2
$2M Sell
22,019
-410
-2% -$37.2K 0.03% 627
2017
Q1
$1.97M Sell
22,429
-6,651
-23% -$584K 0.03% 638
2016
Q4
$2.41M Sell
29,080
-218
-0.7% -$18.1K 0.04% 574
2016
Q3
$2.71M Sell
29,298
-9,929
-25% -$919K 0.04% 527
2016
Q2
$3.05M Sell
39,227
-3,507
-8% -$273K 0.05% 524
2016
Q1
$3.53M Sell
42,734
-10,667
-20% -$880K 0.06% 458
2015
Q4
$5.59M Sell
53,401
-4,506
-8% -$472K 0.09% 323
2015
Q3
$6.1M Sell
57,907
-11,449
-17% -$1.21M 0.1% 294
2015
Q2
$9.49M Buy
69,356
+7,617
+12% +$1.04M 0.13% 217
2015
Q1
$7.69M Buy
61,739
+5,632
+10% +$702K 0.1% 255
2014
Q4
$5.07M Sell
56,107
-3,021
-5% -$273K 0.07% 341
2014
Q3
$4.27M Buy
59,128
+899
+2% +$64.9K 0.06% 381
2014
Q2
$3.62M Buy
58,229
+6,955
+14% +$433K 0.05% 423
2014
Q1
$3.5M Buy
51,274
+6,761
+15% +$461K 0.05% 399
2013
Q4
$3.13M Buy
44,513
+9,067
+26% +$637K 0.05% 414
2013
Q3
$2.56M Buy
35,446
+9,773
+38% +$706K 0.05% 439
2013
Q2
$1.43M Buy
+25,673
New +$1.43M 0.03% 544